Agalsidase beta biosimilar (Bio Sidus S.A.)

阿加糖酶β生物类似药（Bio Sidus S.A.）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAgalsidase beta biosimilar (Bio Sidus S.A.)

Drug Alias Name阿加糖酶β生物仿制药（Bio Sidus S.A.）

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of Actionα-Galactosidase replacements

Targetsα-Galactosidase

Therapy Area/IndicationsFabry Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesBiosidus

China Registration ClassN/A

Develop Information

Active CompaniesBiosidus

Inactive CompaniesN/A

Active IndicationsFabry Disease

Inactive IndicationsN/A

Other Information

ATC CodeA16AB04